Wealth Plan Investment Management, LLC Collegium Pharmaceutical, Inc Transaction History

Wealth Plan Investment Management, LLC

  • $944 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$21.06 - $24.0 $38,518 - $43,896
1,829 Added 6096.67%
1,859 $39,000
Q2 2023

Jul 25, 2023
SELL
$21.06 - $24.0 $38,518 - $43,896
-1,829 Reduced 98.39%
30 $0
Q1 2023

May 08, 2023
BUY
$23.0 - $29.88 $42,757 - $55,546
1,859 New
1,859 $44,000

Others Institutions Holding COLL

# of Institutions
247
Shares Held
37.4M
Call Options Held
59.3K
Put Options Held
9.5K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.03B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Wealth Plan Investment Management, LLC Portfolio

Follow Wealth Plan Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Plan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Plan Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email